Drug Type Small molecule drug |
Synonyms Des-F(6)-quinolone, Desquinolone, Garenoxacin + [14] |
Mechanism Bacterial DNA gyrase inhibitors, Topoisomerase IV inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date JP (31 Jul 2007), |
Regulation- |
Molecular FormulaC24H26F2N2O8S |
InChIKeyIGTHEWGRXUAFKF-NVJADKKVSA-N |
CAS Registry223652-90-2 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Garenoxacin Mesilate Hydrate |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Escherichia Coli Infections | JP | 31 Jul 2023 | |
Escherichia Coli Infections | JP | 31 Jul 2023 | |
Klebsiella Infections | JP | 31 Jul 2023 | |
Klebsiella Infections | JP | 31 Jul 2023 | |
Mycoplasma Infections | JP | 31 Jul 2023 | |
Mycoplasma Infections | JP | 31 Jul 2023 | |
Otitis Media | JP | 31 Jul 2023 | |
Otitis Media | JP | 31 Jul 2023 | |
Pharyngolaryngitis | JP | 31 Jul 2023 | |
Pharyngolaryngitis | JP | 31 Jul 2023 | |
Pneumococcal Infections | JP | 31 Jul 2023 | |
Pneumococcal Infections | JP | 31 Jul 2023 | |
Pneumonia, Bacterial | CN | 25 Jul 2019 | |
Respiratory Tract Infections | CN | 12 Jul 2019 | |
Bacterial Infections | KR | 01 Sep 2009 | |
Acute Bronchitis | JP | 31 Jul 2007 | |
Laryngitis | JP | 31 Jul 2007 | |
Pneumonia | JP | 31 Jul 2007 | |
respiratory tract; infection, chronic | JP | 31 Jul 2007 | |
Sinusitis | JP | 31 Jul 2007 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Bronchitis, Chronic | NDA/BLA | EU | - | |
Community Acquired Pneumonia | NDA/BLA | EU | - | |
Complicated skin and soft tissue infection | NDA/BLA | EU | - | |
Intraabdominal Infections | NDA/BLA | EU | - |